Eureka Therapeutics provides custom services for the
production of recombinant
monoclonal antibodies in mammalian (CHO) cells in amounts ranging from 1-2 mg to 1-10 grams. The antibodies produced are assayed for purity and certified to possess low-endotoxin and nucleic acid levels suitable for preclinical animal studies.
Eureka's state-of-the-art facilities and technical expertise enable the production of:
- 1-2 mgs of recombinant antibody within 30 days
- 100-200 mg within 2 months
- 1-10g within 5 months
Please contact us for more details and service quotes.